Page last updated: 2024-08-24

oseltamivir and Thrombopenia

oseltamivir has been researched along with Thrombopenia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Ahmadi, Z; Chong, BH; Leung, HHL; Perdomo, JS; Wong, R; Yan, F; Zheng, SS1
Cantú-Rodríguez, OG; Colunga-Pedraza, JE; Colunga-Pedraza, PR; De la Garza-Salazar, F; Gómez-Almaguer, D; Gómez-De León, A; Peña-Lozano, SP; Sánchez-Rendón, E; Santana-Hernández, P1
Neunert, C1
Hou, M; Jansen, AJ; Ni, H; Peng, J; Zhao, HG1
Auffret, M; Bigot, P; Coupé, P; Ettahar, NK; Gautier, S; Weinborn, M1
Holodniy, M; Raisch, DW; Straight, TM1
Daunis, JV; López, Cde H; Roca, RF1

Reviews

2 review(s) available for oseltamivir and Thrombopenia

ArticleYear
Oseltamivir as rescue therapy for persistent, chronic, or refractory immune thrombocytopenia: a case series and review of the literature.
    Journal of thrombosis and thrombolysis, 2022, Volume: 54, Issue:2

    Topics: Humans; Oseltamivir; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Treatment Outcome

2022
Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature.
    Pharmacotherapy, 2009, Volume: 29, Issue:8

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Antiviral Agents; Drug Interactions; Female; Humans; Oseltamivir; Probenecid; Thrombocytopenia

2009

Other Studies

5 other study(ies) available for oseltamivir and Thrombopenia

ArticleYear
Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia.
    Haematologica, 2022, 09-01, Volume: 107, Issue:9

    Topics: Animals; Antibodies; Apoptosis; Autoantibodies; Blood Platelets; Humans; Mice; Oseltamivir; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia

2022
Looking long-term: an unmet need in immune thrombocytopenia.
    The Lancet. Haematology, 2021, Volume: 8, Issue:4

    Topics: Dexamethasone; Health Services Needs and Demand; Humans; Oseltamivir; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia

2021
Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia.
    American journal of hematology, 2015, Volume: 90, Issue:5

    Topics: Blood Platelets; Enzyme Inhibitors; Female; Humans; Influenza, Human; Male; Middle Aged; N-Acetylneuraminic Acid; Neuraminidase; Oseltamivir; Platelet Count; Retrospective Studies; Thrombocytopenia; Treatment Outcome

2015
Unexpected platelets elevation in a patient with idiopathic thrombocytopenia treated with oseltamivir for influenza infection.
    Fundamental & clinical pharmacology, 2016, Volume: 30, Issue:5

    Topics: Antiviral Agents; Blood Platelets; Female; Humans; Influenza, Human; Middle Aged; Neuraminidase; Oseltamivir; Platelet Count; Thrombocytopenia

2016
[Pneumonia and the acute respiratory distress syndrome due to influenza A (H1N1) virus].
    Medicina intensiva, 2009, Volume: 33, Issue:9

    Topics: Acute Kidney Injury; Acute Lung Injury; Aged; Antiviral Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disseminated Intravascular Coagulation; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung Neoplasms; Male; Oseltamivir; Pneumonia, Viral; Pulmonary Edema; Respiratory Distress Syndrome; Thrombocytopenia

2009